| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.02B | 33.21B | 27.68B | 24.17B | 19.74B | 1.00B |
| Gross Profit | 12.57B | 11.69B | 10.78B | 9.25B | 7.51B | 605.51M |
| EBITDA | 7.60B | 7.03B | 6.37B | 5.36B | 3.18B | -42.48M |
| Net Income | 2.81B | 2.40B | 3.54B | 1.81B | 1.08B | -122.54M |
Balance Sheet | ||||||
| Total Assets | 37.20B | 32.72B | 25.31B | 22.73B | 15.08B | 910.38M |
| Cash, Cash Equivalents and Short-Term Investments | 4.62B | 4.33B | 4.51B | 3.70B | 2.28B | 99.55M |
| Total Debt | 17.99B | 13.20B | 9.97B | 11.66B | 6.09B | 2.39B |
| Total Liabilities | 24.78B | 20.25B | 14.88B | 15.84B | 9.32B | 738.63M |
| Stockholders Equity | 12.42B | 12.47B | 10.43B | 6.89B | 5.75B | 4.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.03B | 4.70B | 3.63B | 1.10B | -495.40M |
| Operating Cash Flow | 0.00 | 4.94B | 5.39B | 4.19B | 1.69B | -194.73M |
| Investing Cash Flow | 0.00 | -6.61B | -1.20B | -3.00B | -2.76B | -299.17M |
| Financing Cash Flow | 0.00 | 1.53B | -3.38B | 225.00M | 2.11B | 593.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥16.73B | 6.65 | ― | 3.96% | 14.49% | -4.12% | |
69 Neutral | ¥14.44B | 12.09 | ― | 2.51% | 9.36% | 136.48% | |
66 Neutral | ¥42.39B | 25.44 | ― | 0.70% | 5.61% | 18.11% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ¥1.33B | 6.23 | ― | 3.86% | 7.65% | 38.96% | |
51 Neutral | ¥3.88B | -645.05 | ― | ― | -7.97% | -465.26% |